Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, 650118, China.
Yunnan Provincial Key Laboratory of Vector-Borne Diseases Control and Research, Yunnan Institute of Parasitic Diseases, Simao Pu' er, 665000, Yunnan, China.
Sci Rep. 2022 Jun 14;12(1):9844. doi: 10.1038/s41598-022-13230-0.
Chikungunya virus (CHIKV), a highly infectious and rapidly spread viral pathogen, is classified as a pathogenic agent at the biosafety level 3. Operation of live authentic CHIKV needs a specific laboratory with the P3 or above containment, which greatly confines the CHIKV-associated studies. To establish an evaluation system of CHIKV that can be utilized in a BSL2 laboratory, we constructed a pseudovirus (PsV) system of CHIKV containing double reporter genes (ZsGreen1 and luciferase). The fluorescent ZsGreen1 is a convenient and cheap reporter for monitoring the efficiency of transfection and titration of PsV. The enzyme luciferase is a sensitive reporter for the application of PsV to neutralization assay or drug screening. The CHIKV PsV produced in this study, with a titer of up to 3.16 × 10 TU/ml, was confirmed by Western blotting and transmission electronic microscopy (TEM). Finally, we developed a microneutralization assay with the CHIKV PsV produced in this study, which was successfully applied to evaluate neutralizing activities of convalescent sera from CHIKV-infected patients. In summary, we have established a convenient and sensitive double-reporter CHIKV pseudovirus system, which provides a safe and effective platform for screening anti-CHIKV drugs and evaluating vaccines against CHIKV.
基孔肯雅病毒(CHIKV)是一种高度传染性和快速传播的病毒病原体,被归类为生物安全级别 3 的致病因子。操作活的真实 CHIKV 需要具有 P3 或更高防护等级的特定实验室,这极大地限制了与 CHIKV 相关的研究。为了建立可在 BSL2 实验室中使用的 CHIKV 评估系统,我们构建了包含双报告基因(ZsGreen1 和荧光素酶)的 CHIKV 假病毒(PsV)系统。荧光 ZsGreen1 是一种方便且廉价的报告基因,可用于监测 PsV 的转染和滴定效率。酶荧光素酶是一种敏感的报告基因,可用于 PsV 的中和测定或药物筛选应用。本研究中产生的 CHIKV PsV 的滴度高达 3.16×10 TU/ml,通过 Western blot 和透射电子显微镜(TEM)进行了确认。最后,我们使用本研究中产生的 CHIKV PsV 开发了微量中和测定法,并成功地应用于评估 CHIKV 感染患者恢复期血清的中和活性。总之,我们建立了一种方便且敏感的双报告 CHIKV 假病毒系统,为筛选抗 CHIKV 药物和评估针对 CHIKV 的疫苗提供了安全有效的平台。